Submit your email to push it up the queue
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the biochemical and pharmaceutical industry. Established in [year founded], the company has made significant strides in research and development, focusing on innovative solutions for healthcare and life sciences. With a strong operational presence across major regions in Asia, SPH No. 1 is renowned for its core products, which include high-quality active pharmaceutical ingredients (APIs) and advanced biochemical formulations. These offerings are distinguished by their purity and efficacy, catering to a diverse range of therapeutic areas. Recognised for its commitment to quality and innovation, SPH No. 1 has achieved notable milestones, solidifying its market position as a trusted supplier in the pharmaceutical sector. The company continues to drive advancements in biochemistry, contributing to improved health outcomes globally.
How does SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd, headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd, which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, SPH No. 1 Biochemical & Pharmaceutical Co., Ltd is part of a corporate family that may have broader sustainability initiatives. However, there are no documented reduction targets or climate pledges available for this subsidiary. The absence of specific targets or achievements suggests that the company may still be in the early stages of developing its climate strategy. As the industry increasingly focuses on carbon neutrality and sustainability, it is essential for SPH No. 1 Biochemical & Pharmaceutical Co., Ltd to establish clear emissions reduction goals and commitments to align with global climate standards.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.